A Small Group of Pharma Companies Is Making the Bulk of Medicines Necessary for Developing Countries

In the foundation’s sixth Access to Medicine Index released Tuesday, the Netherlands-based group pointed out that a handful of pharmaceutical companies are developing the bulk of urgently needed new medicines for the poor. Those drugs are concentrated on five diseases and are made by five companies, the Access to Medicine Foundation said in its 2018 Access to Medicine Index.